Skip to content
OpenCapital
Get started

Profound Medical PROF Q1 2026 earnings

Reported May 7, 2026 · After market close

Revenue$5.3MBeat by $485.0K
EPS-$0.19Beat by $0.05
Revenue estimate$4.9M
EPS estimate-$0.24

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$4.8M
EPS estimate-$0.22

Financials

Q1 2026

Income statement

See full
Revenue$5.3M+104%
Gross profit$3.8M+107%
Operating income-$8.0M+28.2%
Net income-$7.1M+34.2%
EPS (diluted)$0.19-47.2%

Balance sheet

See full
Cash & equivalents$50.3M+8.3%
Total debt$7.5M+52.8%
Total equity$59.4M+17.0%
Total assets$73.5M+20.7%

Cash flow

See full
Operating cash flow-$8.6M-3.6%

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$266.35M+55.5%
Enterprise value$223.52M+58.6%
P/S14.2×-0.3×

Profitability

See full
Gross margin71.1%+3.4pp
Operating margin-202.6%-51.3pp
Net margin-206.8%-39.0pp

Returns & leverage

See full
Return on equity-70.6%+4.8pp
Debt / equity0.1×0.0×
Current ratio6.6×-4.8×

Segments

By geography

See full
CA$3.6M+319%
US$1.6M+4.7%
DE$150.0K-33.6%

By product

See full
Capital Equipment$2.9M+249%
Recurring Non Capital$2.5M+37.4%

Versus estimates

Revenue

Q1 2026$5.3MBeat by $485.0K
Q4 2025$6.0MMiss by $1.7MQ3 2025$5.2MMiss by $5.3MQ2 2025$2.2MMiss by $2.5MQ1 2025$2.6MMiss by $2.1MQ4 2024$5.3MMiss by $591.4K

Diluted EPS

Q1 2026-$0.19Beat by $0.05
Q4 2025-$0.27In lineQ3 2025-$0.26Beat by $0.12Q2 2025-$0.52Miss by $0.09Q1 2025-$0.36Miss by $0.07Q4 2024-$0.20Beat by $0.11

Ask the moment Profound Medical reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Profound Medical report Q1 2026 earnings?
Profound Medical (PROF) reported Q1 2026 earnings on May 7, 2026 after market close.
What were Profound Medical's Q1 2026 revenue and EPS?
Profound Medical reported revenue of $5.3M and eps of $-0.19 for Q1 2026.
Did Profound Medical beat estimates in Q1 2026?
Revenue beat the consensus estimate of $4.9M by $485.0K. EPS beat the consensus estimate of $-0.24 by $0.05.
How did Profound Medical's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 103.6% from $2.6M a year earlier and eps grew 47.2% from $-0.36.
Where can I find Profound Medical's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001171843-26-003160) and the 10-Q periodic report (0001104659-26-057198) directly on SEC EDGAR. The filing index links above go to sec.gov.